Press Kit

Salvat at a glance

If you are a media professional and wish to receive more information, please send us an email at media@svt.com.

YOU CAN DOWNLOAD OUR PRESS KIT HERE:

SALVAT PRESS KIT

English Version PDF

Download

News

What are we doing right now

Salvat participated in the CPhI North America Congress

09/05/2019/in Salvat International, Salvat Spain, Salvat USA /by admininformatica

Salvat participated in the CPhI North America Congress, which annually gathers the most important companies of North America. This year it was held in Chicago, where we held many meetings with other pharmaceutical companies to explore opportunities that allow us to continue developing our activity in the United States.

Salvat and Pharmaloop participated in the CPhI Worldwide Congress

16/10/2018/in Salvat International, Salvat Spain, Salvat USA /by Carme Lopez

Salvat and Pharmaloop participated in the CPhI Worldwide Congress, which annually gathers the most important companies in the pharmaceutical world. This year it was held in Madrid, where both companies had the opportunity to hold many meetings with other pharmaceutical companies to explore opportunities that allow us to increase our activities internationally.

Laboratorios Salvat has participated in the consortium created for the development of the INDREYE research project “Innovative solutions for the treatment and diagnosis of dry eye syndrome”

11/10/2018/in Salvat Spain /by Carme Lopez

Laboratorios Salvat has participated in the consortium created for the development of the INDREYE research project “Innovative solutions for the treatment and diagnosis of dry eye syndrome” funded by the Spanish National Program of Public-Private Cooperation, subprogram INNPACTO, 2012 call. This program is co-financed by the European Union through the European regional development fund (ERDF/FEDER).

Laboratorios SALVAT maintains the rating of ‘VERY GOOD’ in the PROFARMA call in 2018

12/09/2018/in Salvat Spain /by Carme Lopez

On July 26, 2018, the Spanish Ministry of Industry, Commerce and Tourism, through the General Secretariat of Industry and Small and Medium Enterprises resolved to grant Laboratorios Salvat its classification within Group A: Companies with significant research activity with own pharmaceutical production plant or its own basic or preclinical R & D center, with the […]

Laboratorios Salvat completes patient recruitment for the CIFLOTEX trial

12/09/2018/in Salvat International, Salvat USA /by Carme Lopez

On August 30th 2018, the enrolment of patients into the CIFLOTEX clinical trial was completed. This study has been carried out in 45 US centers, and 493 patients suffering from Acute Otitis Externa (AOE) have been included. The objective of the study is to assess the efficacy and safety of our combination of Ciprofloxacin + […]

Salvat’s Pharmaloop Invests 65 million Euros in Its New Sterile Liquids Plant, located in Alcalá de Henares18/02/2021 - 1:52 pm
The Minister of Industry, Reyes Maroto, visited Salvat’s new facility today, accompanied by the Mayor of Alcalá de Henares, Javier Rodriguez Palacios and Salvat CEO, Alberto Bueno The new 8,500 m² plant is equipped with the most advanced technology, highest quality standards and the capacity to produce more than 350 million units of sterile formulations […]
Salvat Laboratories enters in the chinese market with Cetraxal® Plus Clinical Trial01/02/2021 - 1:48 pm
Salvat has an agreement with Lee’s Pharmaceuticals to distribute Cetraxal® Plus in China Cetraxal® Plus is the only pharmaceutical product in the world that is available in single-dose vials for external otitis and otitis media. It was launched in 2002 in Spain and is already exported to more than 50 countries The Phase III clinical […]
Herpix®, the new oral formula against the Herpes Simplex Virus from Laboratorios Salvat, is chosen as Product of the Year 202125/01/2021 - 10:38 am
The new product from Laboratorios Salvat has been recognised as this year’s most innovative Food Supplement for the Immune System Herpix® is a food supplement formulated from natural extracts which helps slow the replication of the Herpes Simplex Virus (HSV), acting from the inside right from the appearance of the first symptom Herpix®, the new […]